StockWatch
·
Pharmaceuticals
Board Meeting27 Aug 2026, 06:40 pm

Gujarat Themis Biosyn Board Meeting on Sep 1 to Consider Fund Raising

AI Summary

Gujarat Themis Biosyn Ltd has announced a Board of Directors meeting scheduled for September 1, 2026. The primary agenda is to consider and approve raising funds through the issuance of equity shares and/or convertible warrants via a preferential issue on a private placement basis. This move is subject to necessary approvals, including shareholder and stock exchange consent. Concurrently, the company has implemented a trading window closure for designated persons and their immediate relatives, effective until 48 hours after the meeting's outcome is announced, to prevent insider trading.

Key Highlights

  • Board meeting scheduled for September 1, 2026.
  • To consider and approve fund raising via preferential issue.
  • Trading window to remain closed for designated persons.
  • Fund raising subject to shareholder and exchange approvals.